BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22028121)

  • 1. [Two siblings with an IL-12 and IFN-γ production disorder diagnosed with pulmonary mycobacteriosis caused by M. kansasii. Mendelian susceptibility to mycobacterial infection: an overview of literature].
    Nalepa P; Strach M; Rybak-Bąk M; Siedlar M
    Pneumonol Alergol Pol; 2011; 79(6):428-36. PubMed ID: 22028121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-tuberculous mycobacteriosis. What has been coming out].
    Kajiki A
    Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium kansasii Infection in a Patient Receiving Biologic Therapy-Not All Reactive Interferon Gamma Release Assays Are Tuberculosis.
    Saleem N; Saba R; Maddika S; Weinstein M
    Am J Med Sci; 2017 Apr; 353(4):394-397. PubMed ID: 28317629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and genetic heterogeneity of inherited autosomal recessive susceptibility to disseminated Mycobacterium bovis bacille calmette-guérin infection.
    Elloumi-Zghal H; Barbouche MR; Chemli J; Béjaoui M; Harbi A; Snoussi N; Abdelhak S; Dellagi K
    J Infect Dis; 2002 May; 185(10):1468-75. PubMed ID: 11992283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacille Calmette-Guérin infection and disease with fatal outcome associated with a point mutation in the interleukin-12/interleukin-23 receptor beta-1 chain in two Mexican families.
    Pedraza-Sánchez S; Herrera-Barrios MT; Aldana-Vergara R; Neumann-Ordoñez M; González-Hernández Y; Sada-Díaz E; de Beaucoudrey L; Casanova JL; Torres-Rojas M
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e256-60. PubMed ID: 20171917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of non-tuberculous pulmonary mycobacteriosis].
    Sakatani M; Nakajima Y
    Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical mycobacterial infection in a patient with hairy cell leukemia.
    Trizna Z; Tschen J; Natelson EA
    Cutis; 2001 Mar; 67(3):241-2. PubMed ID: 11270299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediastinal and Disseminated Mycobacterium kansasii Disease in GATA2 Deficiency.
    Lovell JP; Zerbe CS; Olivier KN; Claypool RJ; Frein C; Anderson VL; Freeman AF; Holland SM
    Ann Am Thorac Soc; 2016 Dec; 13(12):2169-2173. PubMed ID: 27607353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic predisposition and susceptibility to mycobacterial infections: the IL-12-IFNgamma axis deficiency].
    Picard C; Casanova JL
    Rev Med Brux; 2005 Feb; 26(1):17-9. PubMed ID: 15816335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mendelian predisposition to mycobacterial infections in humans].
    Casanova JL
    J Soc Biol; 2000; 194(1):25-8. PubMed ID: 11107546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the 2007 ATS/IDSA diagnostic criteria for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease.
    Chae DR; Kim YI; Kee SJ; Kim YH; Chi SY; Ban HJ; Kwon YS; Oh IJ; Kim KS; Kim SO; Kim YC; Lim SC
    Respiration; 2011; 82(2):124-9. PubMed ID: 20926850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection: abnormal IL-12 regulation.
    Frucht DM; Holland SM
    J Immunol; 1996 Jul; 157(1):411-6. PubMed ID: 8683146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case report of pulmonary Mycobacterium kansasii infection found regular medical examination in our medical college of nursing].
    Inatomi K
    Kekkaku; 2000 Nov; 75(11):661-4. PubMed ID: 11140089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical usefulness of QuantiFERON TB-2G test for the early diagnosis of pulmonary Mycobacterium kansasii disease.
    Kobashi Y; Mouri K; Miyashita N; Oka M
    Jpn J Infect Dis; 2009 May; 62(3):239-41. PubMed ID: 19468192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium kansasii endobronchial ulcer in a nonimmunocompromised patient.
    Manali ED; Tomford WJ; Liao DW; Farver C; Mehta AC
    Respiration; 2005; 72(3):305-8. PubMed ID: 15942302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of molecular diagnosis on treating Mendelian susceptibility to mycobacterial diseases.
    Wang LH; Yen CL; Chang TC; Liu CC; Shieh CC
    J Microbiol Immunol Infect; 2012 Dec; 45(6):411-7. PubMed ID: 23036270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-12 regulates the production of Bacille Calmette-Guérin-induced interferon-gamma from human cells in a CD40-dependent manner.
    Méndez-Samperio P; Ayala-Verdin HE; Trejo-Echeverria A
    Scand J Immunol; 1999 Jul; 50(1):61-7. PubMed ID: 10404053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and immune functional profiling of patients with suspected Mendelian Susceptibility to Mycobacterial Disease in South Africa.
    van Coller A; Glanzmann B; Cornelissen H; Möller M; Kinnear C; Esser M; Glashoff R
    BMC Immunol; 2021 Sep; 22(1):62. PubMed ID: 34517836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.